Previzion Aksyon Adaptimmune Therapeutics АДР (ADAP)

Adaptimmune Therapeutics

Healthcare · USD · United States of America

TG WA X in ⧉

Dernie pri$0.03Mizajou 25 Sep 2026

Chanjman+50.00%

Previzyon AI: ADAP

1 zour

$0.03

🔒 Debloke Premium

1 semenn

$0.03

🔒 Debloke Premium

1 mwa

$0.03

🔒 Debloke Premium

AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.

Pri lor dernie 6 mwa

Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.

Debloke Premium

🔒 Historik previzion

Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.

Debloke Premium

Sou Konpayi Sa a

Adaptimmune Therapeutics is a biotechnological company that develops immunotherapy based on T -cells for the treatment of cancer.

Aksyon Ki Gen Rapò

TXG10X Genomics Inc Dernie pri$85.71 +1.90%Previzyon AI · 1 zour🔒 Premium ABTAbbott Dernie pri$101.31 +0.24%Previzyon AI · 1 zour🔒 Premium ABBVAbbVie Dernie pri$264.31 -0.31%Previzyon AI · 1 zour🔒 Premium ABCLAbCellera Biologics Dernie pri$12.72 +0.47%Previzyon AI · 1 zour🔒 Premium ACADACADIA Pharmaceuticals Inc Dernie pri$20.68 -6.76%Previzyon AI · 1 zour🔒 Premium ACMRACM Research Inc Dernie pri$77.34 +1.52%Previzyon AI · 1 zour🔒 Premium ADPTAdaptive Biotechnologies Dernie pri$29.45 -0.41%Previzyon AI · 1 zour🔒 Premium ADUSAddus HomeCare Corp Dernie pri$113.07 -0.84%Previzyon AI · 1 zour🔒 Premium

Obtini Previzyon Aksyon AI Aster

Telechaje nou aplikasyon pou previzyon aksyon AI lor iPhone, Android ek Windows

Debloke Premium

Avètisman: Previzyon aksyon ki jenere par AI se pou enfòmasyon sèlman ek pa konstitye konsèy finansye. Rezilta pase pa garanti rezilta futur. Toujou fer ou prop resers ek konsilt yon konseye finansye kalifye avan ou pran desizyon envestisman. Envestisman enplike risk, ki enkli posib pèt kapital.